Log in to save to my catalogue

Human alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha...

Human alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_16151532

Human alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin

About this item

Full title

Human alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin

Publisher

United States

Journal title

The Journal of clinical investigation, 2005-10, Vol.115 (10), p.2801

Language

English

Formats

Publication information

Publisher

United States

More information

Scope and Contents

Contents

Human noncollagenous domain 1 of the alpha1 chain of type IV collagen [alpha1(IV)NC1], or arresten, is derived from the carboxy terminal of type IV collagen. It was shown to inhibit angiogenesis and tumor growth in vivo; however, the mechanisms involved are not known. In the present study we demonstrate that human alpha1(IV)NC1 binds to alpha1beta1...

Alternative Titles

Full title

Human alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmed_primary_16151532

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_16151532

Other Identifiers

ISSN

0021-9738

How to access this item